HPLC Chiral Separation of Methocarbamol Enantiomers on Cyralis CM Column

HPLC Chiral Method for Analysis of Methocarbamol Enantiomers on Cyralis CM Column by SIELC Technologies

High Performance Liquid Chromatography (HPLC) Method for Analysis of Methocarbamol.

Methocarbamol is an drug with the chemical formula C11H15NO5. It is used primarily to treat short-term musculoskeletal pain, especially acute spasms. It is not yet clearly established how the drug works.

This application describes a normal-phase chiral HPLC method for the separation of Methocarbamol enantiomers using SIELC’s Cyralis CM chiral column. Cyralis CM is a cellulose-based chiral stationary phase (CSP) designed for enantiomeric separations, optical purity testing, chiral impurity analysis, and stereoisomer characterization in pharmaceutical, chemical, agrochemical, and fine chemical applications. For best results, the sample should be prepared fresh for analysis.

Methocarbamol can be retained and analyzed using the Cyralis CM stationary phase column. The analysis utilizes an isocratic method with a mobile phase consisting of sodium Hexane and Ethanol,. Detection is performed using UV.

Condition

ColumnCyralis CM, 4.6 x 250 mm, 5 µm, 100 A, normal phase
Mobile PhaseHexane/Ethano
Flow Rate1.0 mL/min
DetectionUV 220 nm
Resolution4.32

Description

Class of CompoundsDrug
Analyzing CompoundsMethocarbamol

Application Column

Cyralis CM

Column Diameter: 4.6 mm
Column Length: 250 mm
Particle Size: 5 µm
Pore Size: 100 A
Column options: normal phase

Add to cart
Application Analytes:
Methocarbamol
Application Detection:
UV Detection
SIELC Technologies usually develops more than one method for each compound. Therefore, this particular method may not be the best available method from our portfolio for your specific application. Before you decide to implement this method in your research, please send us an email to research@sielc.com so we can ensure you get optimal results for your compound/s of interest.